Clinical Trial: Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

Brief Summary: The purpose of this study is to determine the tolerability and optimal dose of cannabidiol (CBD) as an simultaneous treatment in children and young adults with Sturge-Weber syndrome (SWS) and drug resistant epilepsy.